TRPM8
Reactivité: Humain
ELISA, IHC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA (1:1000) Western Blot (1:50-100) Immunohistochemistry (1:10-50) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Bödding, Wissenbach, Flockerzi: "Characterisation of TRPM8 as a pharmacophore receptor." dans: Cell calcium, Vol. 42, Issue 6, pp. 618-28, (2007) (PubMed).
Kiessling, Füssel, Schmitz, Stevanovic, Meye, Weigle, Klenk, Wirth, Rieber: "Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8." dans: The Prostate, Vol. 56, Issue 4, pp. 270-9, (2003) (PubMed).
Tsavaler, Shapero, Morkowski, Laus: "Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins." dans: Cancer research, Vol. 61, Issue 9, pp. 3760-9, (2001) (PubMed).
Antigène
TRPM8
(Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8))